ADC Therapeutics ADCT
NYSE ADCT
$1.45 -0.15 (-9.69%)
As of: Oct 23, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Cash & Current Investments (2019 - 2026)

Updated

ADC Therapeutics (ADCT) reported Cash & Current Investments of $219.11 million for Q2 2026, down 17.2% from $264.56 million a year earlier and down 5.2% from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, ADC Therapeutics posted Cash & Current Investments of $261.34 million, up 4.2% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $250.87 million in FY2024 (-10.0%), $278.6 million in FY2023 (-14.7%), $326.44 million in FY2022 (-30.0%) and $466.54 million in FY2021 (+6.2%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q1 2025.
  • Year over year, Cash & Current Investments gained in two of the last eight quarters, with an average decline of 7.4%.
  • The high point for year-over-year Cash & Current Investments in five years was Q1 2026 (growth of 18.6%); the low point was Q4 2022 (a decline of 30.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $231.01 million (Q1 2026), $261.34 million (Q4 2025) and $234.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 ADC Therapeutics 224.00 Mn -722.19 Mn 16.90 Mn 219.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 219.11 Mn
Mar 31, 2026 231.01 Mn
Dec 31, 2025 261.34 Mn
Sep 30, 2025 234.74 Mn
Jun 30, 2025 264.56 Mn
Mar 31, 2025 194.70 Mn
Dec 31, 2024 250.87 Mn
Sep 30, 2024 274.30 Mn
Jun 30, 2024 300.12 Mn
Mar 31, 2024 234.30 Mn
Dec 31, 2023 278.60 Mn
Sep 30, 2023 310.41 Mn
Jun 30, 2023 347.51 Mn
Mar 31, 2023 310.55 Mn
Dec 31, 2022 326.44 Mn
Sep 30, 2022 380.86 Mn
Jun 30, 2022 376.78 Mn
Mar 31, 2022 430.87 Mn
Dec 31, 2021 466.54 Mn
Sep 30, 2021 530.19 Mn
API Access

ADC Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ADCT&period=max&api_key=YOUR_API_KEY